biztrac. BETA
COMPANY REGISTER PROFILE
932470357 ORG. NO. 2025 ACCOUNTS 7 SECTIONS
Active UPDATED 03.10.2026
Wholesale of pharmaceutical and medical goods

ORLEX AS

Org. no. 932470357 Limited company (AS) Oslo Incorporated 2023 Active
Revenue 2025 NOK 24,000
Operating profit NOK −23,000
Equity NOK −72,000
Incorporated 2023
Share capital NOK 30,000

Signals

1 flags
  • Negativ egenkapital 2025 Bokført egenkapital er negativ (−72k kr).

ORLEX AS is registered as a limited company in Oslo, Oslo with organisation number 932470357. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 2023. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Engroshandel med ortopedi- og apotekvarer.”. The most recent filed accounts, for the 2025 financial year, show NOK 24,000 in revenue and NOK −23,000 in operating profit.

Key figures · 2025

Revenue
NOK 24,000
▼ −42 %
Operating profit
NOK −23,000
▼ −28 %
Equity
NOK −72,000
▼ −1267 %

Financial health · 2025

Liquidity
0.72
Weak
Current assets ÷ current liabilities
Profitability
-33.6%
Not satisfactory
Return on total assets
Solidity
-127.3%
Weak
Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns ORLEX AS?

ORLEX AS
NOK 24,000 rev. · NOK −23,000 profit

ORLEX AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about ORLEX AS

Who owns ORLEX AS?

Musa Tasbas is the largest registered owner, with 100.0%.

What is the revenue of ORLEX AS?

ORLEX AS had revenue of NOK 24,000 in 2025.

Who is the general manager of ORLEX AS?

Musa Tasbas is registered as general manager of ORLEX AS.

Where is ORLEX AS based?

ORLEX AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.